The (POGO) Blog
August 17, 2017
Members of Congress are supporting a Department of Interior executive who says management retaliated against him because he disclosed how climate change is putting Alaskan coastal communities at risk.
April 3, 2017
President Donald Trump’s nominee to head the Food and Drug Administration has deep roots in the pharmaceutical industry he would oversee.
Topics: Public Health and Science
March 28, 2017
By Ari Goldberg
The Project On Government Oversight (POGO) has unveiled its biennial list of 13 policy areas ripe for Congressional action. It includes recommendations for legislative fixes to make the federal government more transparent, accountable, and ethical.
March 3, 2017
President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.
February 22, 2017
The Food and Drug Administration has a brand-new policy bringing greater transparency regarding the agency's advisory committee members. The increased transparency will help address concerns over these members' conflicts of interest and the advice they giv